Logo image of AMTM

AMENTUM HOLDINGS INC (AMTM) Stock Fundamental Analysis

NYSE:AMTM - New York Stock Exchange, Inc. - US0239391016 - Common Stock

23.59  +0.8 (+3.51%)

After market: 23.68 +0.09 (+0.38%)

Fundamental Rating

2

Overall AMTM gets a fundamental rating of 2 out of 10. We evaluated AMTM against 82 industry peers in the Professional Services industry. AMTM has a bad profitability rating. Also its financial health evaluation is rather negative. AMTM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AMTM had negative earnings in the past year.
AMTM had a positive operating cash flow in the past year.
AMTM Yearly Net Income VS EBIT VS OCF VS FCFAMTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.68%, AMTM is doing worse than 65.82% of the companies in the same industry.
The Return On Equity of AMTM (-1.84%) is worse than 68.35% of its industry peers.
AMTM has a Return On Invested Capital of 1.71%. This is in the lower half of the industry: AMTM underperforms 68.35% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AMTM is significantly below the industry average of 13.48%.
Industry RankSector Rank
ROA -0.68%
ROE -1.84%
ROIC 1.71%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
AMTM Yearly ROA, ROE, ROICAMTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

Looking at the Operating Margin, with a value of 2.59%, AMTM is doing worse than 62.03% of the companies in the same industry.
AMTM's Operating Margin has been stable in the last couple of years.
AMTM's Gross Margin of 9.51% is on the low side compared to the rest of the industry. AMTM is outperformed by 91.14% of its industry peers.
AMTM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.59%
PM (TTM) N/A
GM 9.51%
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
AMTM Yearly Profit, Operating, Gross MarginsAMTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10

More info and screens

2

2. Health

2.1 Basic Checks

AMTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AMTM remains at a similar level compared to 1 year ago.
The debt/assets ratio for AMTM has been reduced compared to a year ago.
AMTM Yearly Shares OutstandingAMTM Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M
AMTM Yearly Total Debt VS Total AssetsAMTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.27, we must say that AMTM is in the distress zone and has some risk of bankruptcy.
AMTM's Altman-Z score of 1.27 is on the low side compared to the rest of the industry. AMTM is outperformed by 73.42% of its industry peers.
AMTM has a debt to FCF ratio of 129.97. This is a negative value and a sign of low solvency as AMTM would need 129.97 years to pay back of all of its debts.
The Debt to FCF ratio of AMTM (129.97) is worse than 68.35% of its industry peers.
AMTM has a Debt/Equity ratio of 1.04. This is a high value indicating a heavy dependency on external financing.
AMTM has a worse Debt to Equity ratio (1.04) than 73.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 129.97
Altman-Z 1.27
ROIC/WACC0.17
WACC9.82%
AMTM Yearly LT Debt VS Equity VS FCFAMTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

AMTM has a Current Ratio of 1.57. This is a normal value and indicates that AMTM is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.57, AMTM perfoms like the industry average, outperforming 55.70% of the companies in the same industry.
A Quick Ratio of 1.57 indicates that AMTM should not have too much problems paying its short term obligations.
AMTM has a Quick ratio of 1.57. This is comparable to the rest of the industry: AMTM outperforms 56.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.57
AMTM Yearly Current Assets VS Current LiabilitesAMTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1B 2B 3B

More info and screens

4

3. Growth

3.1 Past

AMTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.86%, which is quite impressive.
Looking at the last year, AMTM shows a small growth in Revenue. The Revenue has grown by 6.65% in the last year.
The Revenue has been growing by 12.53% on average over the past years. This is quite good.
EPS 1Y (TTM)73.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

AMTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 81.08% yearly.
Based on estimates for the next years, AMTM will show a small growth in Revenue. The Revenue will grow by 3.31% on average per year.
EPS Next Y171.15%
EPS Next 2Y81.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.19%
Revenue Next 2Y3.31%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMTM Yearly Revenue VS EstimatesAMTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 5B 10B
AMTM Yearly EPS VS EstimatesAMTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.5 1 1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

AMTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 16.40 indicates a correct valuation of AMTM.
AMTM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AMTM is cheaper than 67.09% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.44, AMTM is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 16.4
AMTM Price Earnings VS Forward Price EarningsAMTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMTM is on the same level as its industry peers.
AMTM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. AMTM is more expensive than 68.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 159.43
EV/EBITDA 21.3
AMTM Per share dataAMTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AMTM's earnings are expected to grow with 81.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.08%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMTM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMENTUM HOLDINGS INC

NYSE:AMTM (1/21/2025, 8:04:00 PM)

After market: 23.68 +0.09 (+0.38%)

23.59

+0.8 (+3.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)12-17 2024-12-17/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change-0.69%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.74B
Analysts82.5
Price Target31.11 (31.88%)
Short Float %5.18%
Short Ratio2.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.4
P/S 0.68
P/FCF 159.43
P/OCF 122.12
P/B 1.29
P/tB N/A
EV/EBITDA 21.3
EPS(TTM)-0.53
EYN/A
EPS(NY)1.44
Fwd EY6.1%
FCF(TTM)0.15
FCFY0.63%
OCF(TTM)0.19
OCFY0.82%
SpS34.48
BVpS18.33
TBVpS-15.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.68%
ROE -1.84%
ROCE 2.17%
ROIC 1.71%
ROICexc 1.79%
ROICexgc 12.44%
OM 2.59%
PM (TTM) N/A
GM 9.51%
FCFM 0.43%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
ROICexc(3y)2.45%
ROICexc(5y)N/A
ROICexgc(3y)14.93%
ROICexgc(5y)N/A
ROCE(3y)2.92%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
F-Score5
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 129.97
Debt/EBITDA 9.92
Cap/Depr 4.38%
Cap/Sales 0.13%
Interest Coverage 0.58
Cash Conversion 10.04%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.57
Altman-Z 1.27
F-Score5
WACC9.82%
ROIC/WACC0.17
Cap/Depr(3y)5.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y171.15%
EPS Next 2Y81.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year2.19%
Revenue Next 2Y3.31%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.17%
EBIT growth 3Y11.69%
EBIT growth 5YN/A
EBIT Next Year106.14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-30.5%
FCF growth 3Y-45.82%
FCF growth 5YN/A
OCF growth 1Y-30.26%
OCF growth 3Y-42.49%
OCF growth 5YN/A